Funding

Vivatides Therapeutics

China · Biotech · Healthtech

Develops extrahepatic RNA-targeting therapeutics

Funding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series A$54MApricot Capital — Role not disclosedHighLight Capital — Role not disclosedQiming Venture Partners — Role not disclosedTF Capital — Role not disclosed

Investors

Apricot CapitalSeries AHighLight CapitalSeries AQiming Venture PartnersSeries ATF CapitalSeries A

Coverage

Apr 10, 2026Vivatides Therapeutics · Series A

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing